Lapisteride
Product Specifications
UNSPSC Description
Lapisteride (CS 891) is an orally active 5α-reductase inhibitor. Lapisteride can be used in cancer research[1].
Target Antigen
5 alpha Reductase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lapisteride.html
Purity
99.0
Solubility
Ethanol : 100 mg/mL (ultrasonic)
Smiles
C[C@@]12[C@](CC[C@@H]2C(NC(C)(C3=CC=C(C=C3)OC)C)=O)([H])[C@@]4([H])[C@@](CC1)([H])[C@@]5([C@@](NC(C=C5)=O)([H])CC4)C
Molecular Weight
464.64
References & Citations
[1]Yada S, et al. Solid phase transition of CS-891 enantiotropes during grinding. Int J Pharm. 2003 Apr 14;255(1-2):69-79.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-106174/Lapisteride-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-106174/Lapisteride-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
142139-60-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARMC6 (Armadillo Repeat-containing Protein 6, MGC19595, R30923_1) (MaxLight 405)
ARMC6 (Armadillo Repeat-containing Protein 6, MGC19595, R30923_1) (MaxLight 405)
ZNF71 CRISPRa sgRNA lentivector (set of three targets)(Human)
